Form 8-K - Current report:
SEC Accession No. 0001193125-24-256699
Filing Date
2024-11-13
Accepted
2024-11-13 09:28:55
Documents
18
Period of Report
2024-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d885519d8k.htm   iXBRL 8-K 61688
2 EX-10.1 d885519dex101.htm EX-10.1 314699
3 EX-10.2 d885519dex102.htm EX-10.2 42632
4 EX-10.3 d885519dex103.htm EX-10.3 30658
5 EX-99.1 d885519dex991.htm EX-99.1 15979
9 GRAPHIC g885519g1113072358336.jpg GRAPHIC 3182
  Complete submission text file 0001193125-24-256699.txt   712009

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA orgo-20241112.xsd EX-101.SCH 2857
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20241112_lab.xml EX-101.LAB 17981
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20241112_pre.xml EX-101.PRE 11263
21 EXTRACTED XBRL INSTANCE DOCUMENT d885519d8k_htm.xml XML 3742
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 241451539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)